Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
The big news this week comes from the USDA. The agency officially proposed rules for the industry, which are available here. For our take on these rules, see Tonya and Renee's post from Tuesday. Not everyone is in love with the rules. As of this writing, over 4,000 people have signed a change.org petition to revise them. Note: in order to comment officially on a proposed rule, please proceed to regulations.gov.
On the campaign trail, Senator Bernie Sanders (I-VT) released a plan to legalize recreational marijuana and expunge past convictions. For earlier coverage of his views, see our post here. The Presidential candidates have different views on cannabis, but they center around how to legalize or decriminalize, not if that should happen.
Academia continues to be a marijuana hotspot. Students in states where medical cannabis is legal are suing their colleges for taking disciplinary action against them for using it.
So what's happening on the state level? Michigan is now (as of today) accepting applications for adult-use marijuana business licenses. In Utah, meanwhile, businesses can now apply for licenses to run medical marijuana dispensaries, which the state calls pharmacies. No, I don't know why.
Shifting our gaze to our neighbor to the South, Mexico has had some problems in its journey to legalization. It appeared that the Senate would vote on a legalization proposal this week, but the legislation has now been referred to another panel for review.
And finally, Molson Coors will soon be selling CBD-infused beverages in Canada. They'll be called Flow Glow and feature two flavors: Goji + Grapefruit and Raspberry + Lemon.
See you next week!
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.